| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |